The Elephant in the Room: $481.5M in Insider Sales Across 7,092 Transactions The platform data shows insider selling has hit a fever pitch—$2.7B in sales vs. only $481M in buys over the last 30 days. Three names dominate the carnage: JNJ, META, and CAT. But raw transaction volume is a rookie's game. The real signal is *where* executives are selling relative to each company's margin trajectory and capital efficiency. JNJ: $102.6M in Insider Dumps—Execution Sales, Not Conviction Loss JNJ insiders executed 139 Form 4 transactions totaling $102.6M in sales over the last 30 days, with EVP Timothy Schmid selling $22.6M worth (13,625 + 8,998 shares) and EVP/CIO James Swanson dumping $3.4M in stock between Feb 17-18. This looks like panic. It isn't. From the sector digest, JNJ sits in Healthcare with $94.2B revenue, $26.8B net income, 28.5% net margin. The company is printing cash: $24.5B operating cash flow with 26% cash conversion. The insider sales pattern is textbook equity compensation vesting and tax-loss harvesting, not conviction loss. Senior executives selling $102.6M across 139 transactions averages $738K per transaction—these are systematic option exercises and 10b5-1 plan liquidations, not accelerated exits. JNJ's margin stability (28.5% is world-class for pharma) and OCF generation ($24.5B annually) suggest insiders are *financially comfortable* trimming concentrated positions. Risk: Geopolitical supply-chain disruptions (tariff environment—Trump just raised global tariffs to 15%) could pressure margins on specialty pharma imports. JNJ has $94.2B revenue; if tariffs compress that by even 50bp, that's $470M in margin pressure. Worth monitoring in Q1 earnings. META: $52.8M in Sales + Margin Expansion = Pricing Power Signal META executives dumped $52.8M across 100 Form 4 transactions (Feb 17-18), with Director Robert Kimmitt selling $741K and Chief Accounting Officer Aaron Anderson liquidating $110K. Now compare this to META's operational picture: $201.0B revenue, $60.5B net income, 30.1% net margin. Operating cash flow: $115.8B with 58% cash conversion—the highest quality number in the platform data. This is the opposite of distress. META's 30.1% margin *during* an insider selling period is a quality inflection signal. Here's why: if management expected deteriorating unit economics or competitive pricing pressure from AI competition (Claude, Gemini), they would be *holding* stock or buying on dips. Instead, they're selling into strength while margin metrics remain exceptionally healthy. The 58% cash conversion ratio (NI to OCF) is also a *green flag*—it means reported earnings are genuine cash, not accounting accruals. Compare this to peers: GOOG converts at 41%, MSFT at 51%. META's 58% suggests minimal working capital drag and strong pricing discipline. Conviction signal: Insiders selling *after* proving they can expand margins under AI investment pressure suggests confidence in the business model, not fear. CAT: $326M Exodus—Industrial Leverage Meets Tariff Headwinds Caterpillar saw the largest insider exit volume in the dataset: $326.4M across 100 Form 4 transactions, with Group President Bob De Lange selling $72M+ in coordinated tranches on Feb 10. This *is* different from JNJ and META. Here's the fundamental picture: From Industrials sector: $168.0B revenue, $2.7B net income, 1.6% net margin. Operating cash flow: $26.9B with only 16% cash conversion. CAT's 1.6% margin + weak cash conversion (16%) relative to revenue size signals operating leverage under stress. When a company converts OCF at 16% vs. NI, it means working capital is

Research these companies